Skip to main content
GutCited

Lactobacillus acidophilus pour Irritable Bowel Syndrome (IBS)

B

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dacidophilus\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

En conclusion

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

Key Study Findings

Randomized Controlled Trial n=200 12 weeks Double-blind
Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable …
Dose: None vs: placebo Outcome: IBS-Global Improvement Scale response Effet: 19.3% vs 8.9% response at day 28 p=0.048

Population: adults with non-constipated irritable bowel syndrome

Meta-Analysis n=3154
Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable …
Dose: None vs: placebo Outcome: quality of life, depression, and anxiety in IBS … Effet: SUCRA=89.7% (B. longum for QoL); SUCRA=95.6% (probiotic combo for depression) None

Population: patients with irritable bowel syndrome

Randomized Controlled Trial n=61 12 weeks Double-blind
Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel …
Dose: None vs: Placebo Outcome: IBS-SSS (100-point reduction) Effet: 45% active vs 33% placebo (P=0.42) P=0.42

Population: IBD patients with IBS symptoms in remission

Randomized Controlled Trial n=110 12 weeks Double-blind
A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for …
Dose: 10^9 CFU L. acidophilus LA-5 + L. paracasei daily vs: Placebo cultured milk Outcome: Depression risk and serotonin levels in IBS patients Effet: None <0.001 (depression score)

Population: IBS patients with normal mood and subthreshold depression

In Vitro
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal …
Dose: None vs: None Outcome: Colitis severity Effet: None None

Population: Crohn's disease patients

Randomized Controlled Trial 4 weeks
Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group …
Dose: 2 g vs: Placebo Outcome: Constipation symptoms Effet: None P = 0.005

Population: IBS patients

Key Statistics

3

Études

350

Participants

Positive

B

Note

Referenced Papers

Diseases (Basel, Switzerland) 2018 50 citations
Alimentary pharmacology & … 2010 4 citations
Neurogastroenterology and motility 2009 81 citations
Minerva gastroenterologica e … 2006 22 citations
Journal of clinical … 2004 298 citations
Journal of clinical … 2004 205 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
1-10 billion CFU/day
ibssupport:
10 billion CFU/day for 4-8 weeks
lactosesupport:
1-2 billion CFU with dairy consumption

Limite supérieure : Generally well-tolerated up to 20 billion CFU/day

Posologies étudiées dans la recherche

Posologie Durée Effet N
None 12 weeks Positive 200
None -- Positive 3154
None 12 weeks Neutral 61
10^9 CFU L. acidophilus LA-5 + L. paracasei daily 12 weeks Positive 110
None -- Positive --
2 g 4 weeks Mixed --
Chitin-glucan + L. acidophilus NCFM 9 weeks Positive --
None -- Neutral --

Moment optimal de prise : On an empty stomach or before meals; may also be taken with dairy

Safety & Side Effects

Effets indésirables signalés

  • Mild gas and bloating during initial use
  • Occasional loose stools
  • Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains)
  • Very rare: bacteremia in immunocompromised individuals

Interactions connues

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)
  • Sulfasalazine (may affect bacterial metabolism)

Apport maximal tolérable : Generally well-tolerated up to 20 billion CFU/day

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Lactobacillus acidophilus help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 350 participants, there is moderate evidence from clinical studies that Lactobacillus acidophilus may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Lactobacillus acidophilus should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus acidophilus?
Reported side effects may include Mild gas and bloating during initial use, Occasional loose stools, Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains), Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus acidophilus and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.